• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病前期和心血管危险因素:初级卫生保健中引导自主决策咨询方法的有效性,一项随机对照试验。

Prediabetes and cardiovascular risk factors: the effectiveness of a guided self-determination counselling approach in primary health care, a randomized controlled trial.

机构信息

School of Health, Business and Natural Sciences-Faculty of Nursing, University of Akureyri, Akureyri, 600, Iceland.

Health Care Institution of North Iceland, Siglufjordur, 580, Iceland.

出版信息

BMC Public Health. 2024 Nov 1;24(1):3035. doi: 10.1186/s12889-024-20538-1.

DOI:10.1186/s12889-024-20538-1
PMID:39487428
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11529228/
Abstract

BACKGROUND

Identify individuals who are at risk of Type 2 diabetes, who also are at a greater risk of developing cardiovascular disease is important. The rapid worldwide increase in diabetes prevalence call for Primary Health Care to find feasible prevention strategies, to reduce patient risk factors and promote lifestyle changes. Aim of this randomized controlled trial was to investigate how a nurse-lead Guided Self-Determination counselling approach can assist people at risk of type 2 diabetes to lower their coronary heart disease risk.

METHODS

In this randomized controlled study, 81 people at risk of developing type 2 diabetes were assigned into an intervention group (n = 39) receiving Guided Self-Determination counselling from Primary Health Care nurses over three months and a control group (n = 42) that received a diet leaflet only. Measurements included the Finnish Diabetes Risk Score questionnaire and biological measurements of Hemoglobin A1c protein, Body Mass Index, fasting blood glucose, Blood pressure, Cholesterol, High-density lipoprotein, and triglycerides, at baseline (time1), 6 (time2) and 9 months (time 3).

RESULTS

A total of 56 participants, equal number in intervention and control groups, completed all measurements. A significant difference between the intervention and control groups, in coronary heart disease risk was not found at 6 nor 9-months. However, within-group data demonstrated that 55.4% of the participants had lower coronary heart disease risk in the next ten years at the 9-month measurement. Indicating an overall 18% relative risk reduction of coronary heart disease risk by participating in the trial, with the number needed to treat for one to lower their risk to be nine. Within the intervention group a significant difference was found between time 1 and 3 in lower body mass index (p = 0.046), hemoglobin A1c level (p = 0.018) and diastolic blood pressure (p = 0.03).

CONCLUSIONS

Although unable to show significant group differences in change of coronary heart disease risk by this 12-weeks intervention, the process of regular measurements and the guided self-determination counselling seem to be beneficial for within-group measures and the overall reduction of coronary heart disease risk factors.

TRIAL REGISTRATION

This study is a part of the registered study 'Effectiveness of Nurse-coordinated Follow-Up Programme in Primary Care for People at Risk of T2DM' at www.

CLINICALTRIALS

gov (NCT04688359) (accessed on 30 December 2020).

摘要

背景

识别患有 2 型糖尿病风险的个体,以及那些有更高心血管疾病风险的个体是很重要的。糖尿病患病率在全球范围内的迅速增长,要求基层医疗保健机构寻找可行的预防策略,降低患者的风险因素并促进生活方式的改变。本随机对照试验的目的是研究护士主导的自主指导咨询方法如何帮助有 2 型糖尿病风险的人降低冠心病风险。

方法

在这项随机对照研究中,81 名有发展为 2 型糖尿病风险的人被分配到干预组(n=39),他们在三个月内接受初级保健护士的自主指导咨询,对照组(n=42)仅接受饮食传单。测量包括芬兰糖尿病风险评分问卷和血红蛋白 A1c 蛋白、体重指数、空腹血糖、血压、胆固醇、高密度脂蛋白和甘油三酯的生物测量,在基线(时间 1)、6 个月(时间 2)和 9 个月(时间 3)。

结果

共有 56 名参与者,干预组和对照组各有 28 名,完成了所有测量。在 6 个月和 9 个月时,干预组和对照组之间的冠心病风险差异均无统计学意义。然而,组内数据显示,在 9 个月的测量中,55.4%的参与者在未来十年内冠心病风险较低。这表明通过参与试验,冠心病风险相对降低了 18%,需要治疗的人数为 9 人,以降低他们的风险。在干预组中,时间 1 与时间 3 之间的身体质量指数(p=0.046)、血红蛋白 A1c 水平(p=0.018)和舒张压(p=0.03)显著降低。

结论

尽管本 12 周干预未能显示出冠心病风险变化的显著组间差异,但定期测量和自主指导咨询的过程似乎对组内措施和冠心病风险因素的整体降低有益。

试验注册

这项研究是在 www.clinicaltrials.gov 上注册的研究“在初级保健中护士协调的随访计划对 T2DM 风险人群的有效性”的一部分(NCT04688359)(于 2020 年 12 月 30 日访问)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c23/11529228/e1e7615e7c33/12889_2024_20538_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c23/11529228/6e55a6afab63/12889_2024_20538_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c23/11529228/e1e7615e7c33/12889_2024_20538_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c23/11529228/6e55a6afab63/12889_2024_20538_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c23/11529228/e1e7615e7c33/12889_2024_20538_Fig2_HTML.jpg

相似文献

1
Prediabetes and cardiovascular risk factors: the effectiveness of a guided self-determination counselling approach in primary health care, a randomized controlled trial.糖尿病前期和心血管危险因素:初级卫生保健中引导自主决策咨询方法的有效性,一项随机对照试验。
BMC Public Health. 2024 Nov 1;24(1):3035. doi: 10.1186/s12889-024-20538-1.
2
ForgIng New paths in DIabetes PrevenTion (FINDIT): Study Protocol for a Randomized Controlled Trial.糖尿病预防新路径研究(FINDIT):一项随机对照试验的研究方案
Trials. 2017 Apr 8;18(1):167. doi: 10.1186/s13063-017-1887-6.
3
Mobile Delivery of the Diabetes Prevention Program in People With Prediabetes: Randomized Controlled Trial.移动医疗在糖尿病前期人群中应用糖尿病预防计划的随机对照试验。
JMIR Mhealth Uhealth. 2020 Jul 8;8(7):e17842. doi: 10.2196/17842.
4
Effectiveness of a low-intensity nurse-led lifestyle intervention on glycaemic control in individuals with prediabetes: The PREDIPHONE randomized controlled clinical trial.低强度护士主导的生活方式干预对糖尿病前期个体血糖控制的有效性:PREDIPHONE随机对照临床试验
Int J Nurs Stud. 2025 May;165:105034. doi: 10.1016/j.ijnurstu.2025.105034. Epub 2025 Feb 22.
5
Behavioural interventions to promote physical activity in a multiethnic population at high risk of diabetes: PROPELS three-arm RCT.促进多种族高危糖尿病人群进行身体活动的行为干预:PROPELS 三臂 RCT 研究。
Health Technol Assess. 2021 Dec;25(77):1-190. doi: 10.3310/hta25770.
6
Evaluation of an adapted version of the Diabetes Prevention Program for low- and middle-income countries: A cluster randomized trial to evaluate "Lifestyle Africa" in South Africa.评价《糖尿病预防计划》在中低收入国家的适应版本:在南非评估“非洲生活方式”的一项群组随机试验。
PLoS Med. 2022 Apr 15;19(4):e1003964. doi: 10.1371/journal.pmed.1003964. eCollection 2022 Apr.
7
Using HbA1c measurements and the Finnish Diabetes Risk Score to identify undiagnosed individuals and those at risk of diabetes in primary care.使用糖化血红蛋白测量值和芬兰糖尿病风险评分在初级保健中识别未诊断的个体和糖尿病高危个体。
BMC Public Health. 2023 Jan 31;23(1):211. doi: 10.1186/s12889-023-15122-y.
8
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
9
The effect of medical nutrition therapy by a registered dietitian nutritionist in patients with prediabetes participating in a randomized controlled clinical research trial.注册营养师进行的医学营养治疗对参与随机对照临床研究试验的糖尿病前期患者的影响。
J Acad Nutr Diet. 2014 Nov;114(11):1739-48. doi: 10.1016/j.jand.2014.07.020. Epub 2014 Sep 11.
10
Effects of a Technology-Assisted Integrated Diabetes Care Program on Cardiometabolic Risk Factors Among Patients With Type 2 Diabetes in the Asia-Pacific Region: The JADE Program Randomized Clinical Trial.亚太地区 2 型糖尿病患者应用技术辅助综合糖尿病护理方案对其代谢相关心血管风险因素的影响:JADE 项目随机临床试验。
JAMA Netw Open. 2021 Apr 1;4(4):e217557. doi: 10.1001/jamanetworkopen.2021.7557.

本文引用的文献

1
Cardiovascular Benefits of GLP-1 Receptor Agonists in Patients Living with Obesity or Overweight: A Meta-analysis of Randomized Controlled Trials.GLP-1 受体激动剂在肥胖或超重患者中的心血管获益:随机对照试验的荟萃分析。
Am J Cardiovasc Drugs. 2024 Jul;24(4):509-521. doi: 10.1007/s40256-024-00647-3. Epub 2024 May 11.
2
Interprofessional follow-up for people at risk of type 2 diabetes in primary healthcare - a randomized controlled trial with embedded qualitative interviews.多专业团队对 2 型糖尿病高危人群在初级卫生保健中的随访-一项随机对照试验,嵌入定性访谈。
Scand J Prim Health Care. 2024 Sep;42(3):450-462. doi: 10.1080/02813432.2024.2337071. Epub 2024 Apr 8.
3
Low Awareness of Diabetes as a Major Risk Factor for Cardiovascular Disease in Middle- and High-Income Countries.
中高收入国家对糖尿病是心血管疾病主要危险因素的认知度较低。
Diabetes Care. 2024 Mar 1;47(3):379-383. doi: 10.2337/dc23-1731.
4
Evaluation of an interprofessional follow-up intervention among people with type 2 diabetes in primary care-A randomized controlled trial with embedded qualitative interviews.评价初级保健中 2 型糖尿病患者的跨专业随访干预 - 一项随机对照试验,嵌入定性访谈。
PLoS One. 2023 Nov 15;18(11):e0291255. doi: 10.1371/journal.pone.0291255. eCollection 2023.
5
Exploring the Complex Connection Between Diabetes and Cardiovascular Disease: Analyzing Approaches to Mitigate Cardiovascular Risk in Patients With Diabetes.探索糖尿病与心血管疾病之间的复杂联系:分析降低糖尿病患者心血管风险的方法。
Cureus. 2023 Aug 21;15(8):e43882. doi: 10.7759/cureus.43882. eCollection 2023 Aug.
6
Self-determination theory interventions versus usual care in people with diabetes: a systematic review with meta-analysis and trial sequential analysis.自我决定理论干预与糖尿病患者常规护理的比较:系统评价与荟萃分析和试验序贯分析。
Syst Rev. 2023 Sep 6;12(1):158. doi: 10.1186/s13643-023-02308-z.
7
Can Waist-to-Height Ratio and Health Literacy Be Used in Primary Care for Prioritizing Further Assessment of People at T2DM Risk?腰高比和健康素养可否用于初级保健,以优先评估 T2DM 风险人群?
Int J Environ Res Public Health. 2023 Aug 18;20(16):6606. doi: 10.3390/ijerph20166606.
8
Change in the Relation Between Age and Cardiovascular Events Among Men and Women With Diabetes Compared With Those Without Diabetes in 1994-1999 and 2014-2019: A Population-Based Cohort Study.1994 - 1999年和2014 - 2019年糖尿病患者与非糖尿病患者中年龄与心血管事件关系的变化:一项基于人群的队列研究
Diabetes Care. 2023 Oct 1;46(10):e200-e202. doi: 10.2337/dc23-0952.
9
Clusters of prediabetes and type 2 diabetes stratify all-cause mortality in a cohort of participants undergoing invasive coronary diagnostics.在接受侵入性冠状动脉诊断的参与者队列中,糖尿病前期和 2 型糖尿病的聚类分层了全因死亡率。
Cardiovasc Diabetol. 2023 Aug 17;22(1):211. doi: 10.1186/s12933-023-01923-3.
10
Challenges and solutions in clinical research during the COVID-19 pandemic: A narrative review.2019年冠状病毒病大流行期间临床研究中的挑战与解决方案:一篇叙述性综述。
Health Sci Rep. 2023 Aug 6;6(8):e1482. doi: 10.1002/hsr2.1482. eCollection 2023 Aug.